293 related articles for article (PubMed ID: 32566054)
1. Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience.
Evers G; Schulze AB; Thrull M; Hering JP; Schülke C; Wiewrodt R; Wittkowski H; Schmidt LH; Mohr M
Can Respir J; 2020; 2020():4019608. PubMed ID: 32566054
[TBL] [Abstract][Full Text] [Related]
2. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.
Veith M; Tüffers J; Peychev E; Klemmer A; Kotke V; Janciauskiene S; Wilhelm S; Bals R; Koczulla AR; Vogelmeier CF; Greulich T
Int J Chron Obstruct Pulmon Dis; 2020; 15():2827-2836. PubMed ID: 33192056
[TBL] [Abstract][Full Text] [Related]
3. Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.
Hernández-Pérez JM; Ramos-Díaz R; Vaquerizo-Pollino C; Pérez JA
Pulmonology; 2023; 29(3):214-220. PubMed ID: 35346640
[TBL] [Abstract][Full Text] [Related]
4. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
[TBL] [Abstract][Full Text] [Related]
5. Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
Piloni D; Ottaviani S; Saderi L; Corda L; Baderna P; Barzon V; Balderacchi AM; Seebacher C; Balbi B; Albicini F; Corino A; Mennitti MC; Tirelli C; Spreafico F; Bosio M; Mariani F; Sotgiu G; Corsico AG; Ferrarotti I
Minerva Med; 2024 Feb; 115(1):23-31. PubMed ID: 37021471
[TBL] [Abstract][Full Text] [Related]
6. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
7. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
Miravitlles M; Turner AM; Torres-Duran M; Tanash H; Rodríguez-García C; López-Campos JL; Chlumsky J; Guimaraes C; Rodríguez-Hermosa JL; Corsico A; Martinez-González C; Hernández-Pérez JM; Bustamante A; Parr DG; Casas-Maldonado F; Hecimovic A; Janssens W; Lara B; Barrecheguren M; González C; Stolk J; Esquinas C; Clarenbach CF
Respir Res; 2022 Dec; 23(1):352. PubMed ID: 36527073
[TBL] [Abstract][Full Text] [Related]
8. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.
Greulich T; Nell C; Herr C; Vogelmeier C; Kotke V; Wiedmann S; Wencker M; Bals R; Koczulla AR
Orphanet J Rare Dis; 2016 Jun; 11(1):75. PubMed ID: 27282198
[TBL] [Abstract][Full Text] [Related]
9. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
11. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
13. Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.
Belmonte I; Nuñez A; Barrecheguren M; Esquinas C; Pons M; López-Martínez RM; Ruiz G; Blanco-Grau A; Ferrer R; Genescà J; Miravitlles M; Rodríguez-Frías F
Int J Chron Obstruct Pulmon Dis; 2020; 15():2421-2431. PubMed ID: 33116457
[TBL] [Abstract][Full Text] [Related]
14. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
15. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
Fregonese L; Stolk J
Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
[TBL] [Abstract][Full Text] [Related]
16. Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency.
Greulich T; Rodríguez-Frias F; Belmonte I; Klemmer A; Vogelmeier CF; Miravitlles M
Respir Res; 2018 Aug; 19(1):151. PubMed ID: 30103740
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.
Al-Jameil N; Hassan AA; Hassanato R; Isac SR; Otaiby MA; Al-Shareef F; Al-Maarik B; Ajeyan IA; Al-Bahloul K; Ghani S; Al-Torbak D
Medicine (Baltimore); 2017 Oct; 96(42):e8320. PubMed ID: 29049242
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
19. Sanger sequencing solved a cryptic case of severe alpha₁-antitrypsin deficiency.
Zhan SH; Abboud RT; Jung B; Kuchinka B; Ralston D; Casey B; Mattman A
Clin Biochem; 2012 Apr; 45(6):499-501. PubMed ID: 22330941
[TBL] [Abstract][Full Text] [Related]
20. The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes.
Nakanishi T; Forgetta V; Handa T; Hirai T; Mooser V; Lathrop GM; Cookson WOCM; Richards JB
Eur Respir J; 2020 Dec; 56(6):. PubMed ID: 32675199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
